| Serial Number | 90301321 |
| Word Mark | ADC THERAPEUTICS |
| Filing Date | Thursday, November 5, 2020 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Friday, July 12, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, May 24, 2022 |
| Description of Mark | The mark consists of the letters "ADC" above the word "THERAPEUTICS". The letters "ADC" are in darker and lighter shades of blue. An orange wave element extends across the letter "A" to a shared edge of the letters "D" and "C". The word "THERAPEUTICS" is orange. |
| Goods and Services | Pharmaceutical preparations for use in the prevention of cancer and tumors; pharmaceutical preparations for use in the prevention of infectious, oncological, inflammatory, immune, autoimmune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and biological preparations in the nature of pharmaceutical and biological preparations for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of infectious, oncological, inflammatory, immune, autoimmune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and substances for conditioning patients to receive therapies for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic agents, preparations, and substances for medical purposes; reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays to test tissue for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic kits comprised of medical diagnostic reagents and assays to test bodily fluids for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; medical diagnostic assays for testing body fluids; medical diagnostic assays for testing body tissue; diagnostic kits comprised of medical diagnostic assays to test for cell expressions for use in identifying pharmaceutical preparations and therapies for treating medical diseases, disorders, and conditions in humans |
| Indication of Colors claimed | The color(s) blue and orange is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "THERAPEUTICS" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 6, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ADC Therapeutics SA |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Epalinges 1066 CH |
| Party Name | ADC Therapeutics SA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Epalinges 1066 CH |
| Event Date | Event Description |
| Monday, November 9, 2020 | NEW APPLICATION ENTERED |
| Wednesday, January 6, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, February 2, 2021 | ASSIGNED TO EXAMINER |
| Saturday, February 6, 2021 | NON-FINAL ACTION WRITTEN |
| Saturday, February 6, 2021 | NON-FINAL ACTION E-MAILED |
| Saturday, February 6, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, August 5, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, August 5, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, August 6, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 6, 2021 | FINAL REFUSAL WRITTEN |
| Wednesday, October 6, 2021 | FINAL REFUSAL E-MAILED |
| Wednesday, October 6, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, April 6, 2022 | EXPARTE APPEAL RECEIVED AT TTAB |
| Wednesday, April 6, 2022 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Wednesday, April 6, 2022 | EX PARTE APPEAL-INSTITUTED |
| Wednesday, April 6, 2022 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, April 7, 2022 | ASSIGNED TO LIE |
| Tuesday, April 12, 2022 | ASSIGNED TO LIE |
| Wednesday, April 13, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 13, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 20, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 20, 2022 | EXPARTE APPEAL TERMINATED |
| Wednesday, May 4, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 24, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 24, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 19, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, January 18, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, January 18, 2023 | SOU EXTENSION 1 FILED |
| Wednesday, January 18, 2023 | SOU EXTENSION 1 GRANTED |
| Friday, January 20, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, July 13, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, July 13, 2023 | SOU EXTENSION 2 FILED |
| Thursday, July 13, 2023 | SOU EXTENSION 2 GRANTED |
| Saturday, July 15, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, January 18, 2024 | DIVISIONAL REQUEST RECEIVED |
| Thursday, January 18, 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
| Monday, February 5, 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, January 18, 2024 | SOU EXTENSION 3 FILED |
| Thursday, January 18, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, February 26, 2024 | DIVISIONAL PROCESSING COMPLETE |
| Monday, February 26, 2024 | SOU EXTENSION 3 GRANTED |
| Tuesday, February 27, 2024 | CORRECTED NOA E-MAILED |
| Tuesday, February 27, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, July 12, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, July 12, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, July 12, 2024 | SOU EXTENSION 4 GRANTED |
| Friday, July 12, 2024 | SOU EXTENSION 4 FILED |